美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

MATTHEWS EMERGING MARKETS DISCOVERY ACTIVE ETF

29.90

+0.22630.76%

成交量：810

成交額：2.42萬

市值：2,152.80萬

市盈率：- -

高：29.90

開：29.90

低：29.90

收：29.67

52周最高：32.57

52周最低：24.64

股本：72.00萬

流通股本：72.00萬

量比：0.86

換手率：0.11%

股息：0.72

股息率：2.39%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

諾華前高管張穎出任傳奇生物CEO，老東家卻正值「多事之秋」

每日经济新闻

傳奇生物任命張英格麗為首席執行官；股價上漲

諾華前中國總裁張穎加盟傳奇生物，擔任首席執行官

Legend Biotech 聘請諾華資深高管張英格擔任首席執行官

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/MEMS"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MEMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEMS\",,,,,undefined,":{"symbol":"MEMS","market":"US","secType":"STK","nameCN":"MATTHEWS EMERGING MARKETS DISCOVERY ACTIVE ETF","latestPrice":29.9,"timestamp":1789586918727,"preClose":29.6737,"halted":0,"volume":810,"delay":0,"changeRate":0.007626281859019886,"floatShares":720000,"shares":720000,"eps":0,"marketStatus":"交易中","change":0.2263,"latestTime":"09-16 15:39:37 EDT","open":29.9,"high":29.9,"low":29.9,"amount":24213.66372,"amplitude":0,"askPrice":29.61,"askSize":100,"bidPrice":29.55,"bidSize":500,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":29.6737,"sharesOutstanding":720000,"nav":30.495,"aum":21956334.47,"dividendRate":0.023926,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":29.66,"preClose":29.6737,"latestTime":"16:10 EDT","volume":6,"amount":177.9948,"timestamp":1789503007393,"change":-0.0137,"changeRate":-0.000462,"amplitude":0},"volumeRatio":0.855323},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEMS\",,,,,undefined,":{"symbol":"MEMS","floatShares":720000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.855323,"shares":720000,"dividePrice":0.7154,"high":29.9,"amplitude":0,"preClose":29.6737,"low":29.9,"week52Low":24.6357,"pbRate":"--","week52High":32.565,"institutionHeld":0,"latestPrice":29.9,"committee":0.666667,"eps":0,"divideRate":0.023926,"volume":810,"delay":0,"ttmEps":0,"open":29.9,"prevYearClose":25.545,"prevWeekClose":30.7033,"prevMonthClose":30.6997,"prevQuarterClose":31.7347,"fiveDayClose":31.1815,"twentyDayClose":30.6082,"sixtyDayClose":32.4699},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEMS\",params:#limit:5,,,undefined,":[{"date":"2025-12-17","symbol":"MEMS","amount":0.71648,"announcedDate":"2025-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-17","defaultRemindTime":1765981800000,"name":"MATTHEWS EMERGING MARKETS DISCOVERY ACTIVE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-22","payableDate":"2025-12-17","currency":"USD","dateTimestamp":1765947600000,"payDate":"2025-12-22"},{"date":"2024-12-18","symbol":"MEMS","amount":0.33495,"announcedDate":"2024-12-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-18","defaultRemindTime":1734532200000,"name":"MATTHEWS EMERGING MARKETS DISCOVERY ACTIVE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-23","payableDate":"2024-12-18","currency":"USD","dateTimestamp":1734498000000,"payDate":"2024-12-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEMS\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-18","recordDate":"2024-12-18","paymentDate":"2024-12-23","value":0.33495,"currency":"USD"},{"executeDate":"2025-12-17","recordDate":"2025-12-17","paymentDate":"2025-12-22","value":0.71648,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEMS\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEMS\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667675210","title":"諾華前高管張穎出任傳奇生物CEO，老東家卻正值「多事之秋」","url":"https://stock-news.laohu8.com/highlight/detail?id=2667675210","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667675210?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 09:15","pubTimestamp":1789521317,"startTime":"0","endTime":"0","summary":"9月15日，CAR-T细胞疗法企业传奇生物（LEGN）宣布，董事会已任命张颖为首席执行官（CEO），自2026年9月15日起生效。张颖将接替自2026年7月起出任临时首席执行官的AlanBash，后者将继续担任CARVYKTI业务总裁。在加入传奇生物前，张颖曾在诺华任职超过15年，并担任过诺华中国区总裁兼董事总经理。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609163875615778.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609163875615778.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE0009355771.USD","IE00B4R5TH58.HKD","BK4585","MEDX","LEGN","BK4139","BK4588","IE00B2B36J28.USD","BK4578","LU0070302665.USD","MEDI","LU0320765489.SGD","NVS","MEMS","IE00BJT1NW94.SGD","BK4532","BK4505","IE00BFTCPJ56.SGD","BK4007","LU0211331839.USD","PPH","IE0002141913.USD","CANC","IE00BJJMRZ35.SGD","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667647510","title":"傳奇生物任命張英格麗為首席執行官；股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2667647510","media":"路透中文","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667647510?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 20:50","pubTimestamp":1789476616,"startTime":"0","endTime":"0","summary":"BUZZ-传奇生物任命张英格丽为首席执行官；股价上涨9月15日-** 制药公司传奇生物（LEGN.O）股价在盘前交易中上涨2.6%，至19.02美元** 该公司任命曾长期任职于诺华（NOVN.S）的高管张英格丽为首席执行官 (link)** LEGN同时表示，此前担任临时首席执行官的巴什（Alan Bash）将回归其原职，继续担任Carvykti业务总裁** 8月，该公司第二季度业绩超出市场预期** 16家券商中有11家对该股评级为“买入”或更高，5家为“持有”；目标价中位数为56美元——伦敦证券交易所集团（LSEG）汇编数据** 截至前一交易日收盘，该股年内累计跌幅达14.8%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4T4570WJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","MEMS","CANC","BK4139","BK4588","MEDI","BK4585","LEGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667822647","title":"諾華前中國總裁張穎加盟傳奇生物，擔任首席執行官","url":"https://stock-news.laohu8.com/highlight/detail?id=2667822647","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667822647?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 20:43","pubTimestamp":1789476228,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B4R5TH58.HKD","LU0211331839.USD","BK4585","LEGN","BK4139","CANC","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4578","NVS","BK4588","IE00BJT1NW94.SGD","BK4505","IE0009355771.USD","BK4007","MEDX","IE00B2B36J28.USD","MEMS","MEDI","BK4532","LU0208291251.USD","LU0320765489.SGD","IE00BJJMRZ35.SGD","PPH","LU0070302665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667647830","title":"Legend Biotech 聘請諾華資深高管張英格擔任首席執行官","url":"https://stock-news.laohu8.com/highlight/detail?id=2667647830","media":"路透中文","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667647830?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 20:43","pubTimestamp":1789476212,"startTime":"0","endTime":"0","summary":"Legend Biotech 聘请诺华资深高管张英格担任首席执行官路透9月15日-Legend Biotech周二任命诺华资深高管张英格为首席执行官，即日起生效。该公司寄望于这位行业资深人士，以引领其业务在重磅抗癌药物Carvykti之外实现进一步扩张。张英格此前担任诺华国际首席商务官，此前曾领导这家瑞士制药巨头的中国业务。诺华在接连遭遇临床试验挫折后，面临大股东  施加的压力，要求对其董事会进行改组。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4T4570VG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","CANC","LEGN","MEDI","MEMS","BK4588","BK4505"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MEMS\",params:#limit:6,delay:false,,,undefined,":[]}}